A comparison of methods for model selection when estimating individual treatment effects
暂无分享,去创建一个
Robert Tibshirani | Alejandro Schuler | Nigam Shah | Michael Baiocchi | R. Tibshirani | N. Shah | M. Baiocchi | Alejandro Schuler
[1] Sören R. Künzel,et al. Meta-learners for Estimating Heterogeneous Treatment Effects using Machine Learning , 2017 .
[2] Trevor Hastie,et al. Some methods for heterogeneous treatment effect estimation in high dimensions , 2017, Statistics in medicine.
[3] Sherri Rose,et al. Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. , 2011, American journal of epidemiology.
[4] S. Dudoit,et al. Asymptotics of cross-validated risk estimation in estimator selection and performance assessment , 2005 .
[5] David Simchi-Levi,et al. Uplift Modeling with Multiple Treatments and General Response Types , 2017, SDM.
[6] S. Matza,et al. Psychological targeting as an effective approach to digital mass persuasion , 2017 .
[7] S. Athey,et al. Generalized random forests , 2016, The Annals of Statistics.
[8] James M. Robins,et al. Unified Methods for Censored Longitudinal Data and Causality , 2003 .
[9] Jennifer Hill,et al. Automated versus Do-It-Yourself Methods for Causal Inference: Lessons Learned from a Data Analysis Competition , 2017, Statistical Science.
[10] Eva Ascarza. Retention Futility: Targeting High-Risk Customers Might be Ineffective , 2018 .
[11] Trevor Hastie,et al. Model Assessment and Selection , 2009 .
[12] Richard L Kravitz,et al. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. , 2004, The Milbank quarterly.
[13] D. Rubin. Causal Inference Using Potential Outcomes , 2005 .
[14] N. Hjort,et al. The Focused Information Criterion , 2003 .
[15] Sylvain Arlot,et al. A survey of cross-validation procedures for model selection , 2009, 0907.4728.
[16] David H. Wolpert,et al. The Lack of A Priori Distinctions Between Learning Algorithms , 1996, Neural Computation.
[17] Stefan Wager,et al. High-dimensional regression adjustments in randomized experiments , 2016, Proceedings of the National Academy of Sciences.
[18] Pierre Gutierrez,et al. Causal Inference and Uplift Modelling: A Review of the Literature , 2017, PAPIs.
[19] Catherine P. Bradshaw,et al. Assessing the Generalizability of Randomized Trial Results to Target Populations , 2015, Prevention Science.
[20] Craig A. Rolling,et al. Model selection for estimating treatment effects , 2014 .
[21] David Simchi-Levi,et al. A Practically Competitive and Provably Consistent Algorithm for Uplift Modeling , 2017, 2017 IEEE International Conference on Data Mining (ICDM).
[22] Susan Athey,et al. Recursive partitioning for heterogeneous causal effects , 2015, Proceedings of the National Academy of Sciences.
[23] Peter C. Austin,et al. Using Ensemble-Based Methods for Directly Estimating Causal Effects: An Investigation of Tree-Based G-Computation , 2012, Multivariate behavioral research.
[24] Jennifer L. Hill,et al. Bayesian Nonparametric Modeling for Causal Inference , 2011 .
[25] Martin Jullum,et al. Focused Information criteria for selecting among parametric and nonparametric models , 2012 .
[26] Adam Kapelner,et al. Inference for the Effectiveness of Personalized Medicine with Software , 2014 .
[27] J. Hanley,et al. The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.
[28] Xinkun Nie,et al. Learning Objectives for Treatment Effect Estimation , 2017 .
[29] M. Gail,et al. Testing for qualitative interactions between treatment effects and patient subsets. , 1985, Biometrics.
[30] Jodi B. Segal,et al. Understanding Heterogeneity of Treatment Effects in Pragmatic Trials , 2012 .
[31] Patrick Rossignol,et al. Individualizing treatment choices in the systolic blood pressure intervention trial , 2018, Journal of hypertension.